There is demonstrated evidence that medications used for treating opioid use disorder (MOUD)—such as buprenorphine, methadone, and extended-release naltrexone—are effective at treating opioid use disorder (OUD) and reducing associated harms. However, these medications are heavily underutilized, largely due to the under-supply of providers trained and willing to prescribe the medications.

This article discusses physicians' comparative beliefs about medications used to treat opioid use disorder and their perceived barriers to prescribing them.